GNNSF
Price:
$2.12
Market Cap:
$4.21B
Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in North America, Europe, the People's Republic of China, Japan, the other Asia Pacific regions, and internationally. It operates through four segments: Life Science Services and Products, Biologics Development Services, Industrial Synthetic Biology Products, and Cell Therapy. The Life Science Services and Products segment provides research services in various categories, including gene synthesis and molecular cloning, oligonucleotide synthesis, protein engineering, peptide synthesis, antibody development, molecular diagnostics tools, and genome edi...[Read more]
Industry
Biotechnology
IPO Date
2017-09-28
Stock Exchange
OTC
Ticker
GNNSF
According to Genscript Biotech Corporation’s latest financial reports and current stock price. The company's current ROE is 71.23%. This represents a change of 395.75% compared to the average of 14.37% of the last 4 quarters.
The mean historical ROE of Genscript Biotech Corporation over the last ten years is -0.02%. The current 71.23% ROE has changed -324965.48% with respect to the historical average. Over the past ten years (40 quarters), GNNSF's ROE was at its highest in in the December 2024 quarter at 72.60%. The ROE was at its lowest in in the December 2021 quarter at -25.58%.
Average
-0.02%
Median
-1.22%
Minimum
-34.29%
Maximum
68.54%
Discovering the peaks and valleys of Genscript Biotech Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 50.88%
Maximum Annual ROE = 68.54%
Minimum Annual Increase = -1098.66%
Minimum Annual ROE = -34.29%
| Year | ROE | Change |
|---|---|---|
| 2024 | 68.54% | -1098.66% |
| 2023 | -6.86% | -69.43% |
| 2022 | -22.45% | -34.54% |
| 2021 | -34.29% | 50.88% |
| 2020 | -22.73% | -10.22% |
| 2019 | -25.32% | -671.17% |
| 2018 | 4.43% | -63.04% |
| 2017 | 11.99% | -18.60% |
| 2016 | 14.73% | 25.63% |
| 2015 | 11.73% | 17.21% |
The current ROE of Genscript Biotech Corporation (GNNSF) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
13.08%
5-year avg
-3.56%
10-year avg
-0.02%
Genscript Biotech Corporation’s ROE is greater than Shanghai Junshi Biosciences Co., Ltd. (-15.79%), less than Laboratorios Farmaceuticos Rovi, S.A. (23.26%), greater than InnoCare Pharma Limited (-3.10%), less than Camurus AB (publ) (21.18%), less than ALK-Abelló A/S (18.18%), less than Zealand Pharma A/S (64.52%), less than Siegfried Holding AG (15.38%), less than Carl Zeiss Meditec AG (7.27%), less than Welcia Holdings Co., Ltd. (7.33%), less than Sumitomo Pharma Co., Ltd. (12.08%),
| Company | ROE | Market cap |
|---|---|---|
| -15.79% | $5.81B | |
| 23.26% | $4.63B | |
| -3.10% | $3.18B | |
| 21.18% | $3.83B | |
| 18.18% | $7.26B | |
| 64.52% | $5.62B | |
| 15.38% | $4.58B | |
| 7.27% | $4.55B | |
| 7.33% | $3.41B | |
| 12.08% | $4.55B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genscript Biotech Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Genscript Biotech Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Genscript Biotech Corporation's ROE?
How is the ROE calculated for Genscript Biotech Corporation (GNNSF)?
What is the highest ROE for Genscript Biotech Corporation (GNNSF)?
What is the 3-year average ROE for Genscript Biotech Corporation (GNNSF)?
What is the 5-year average ROE for Genscript Biotech Corporation (GNNSF)?
How does the current ROE for Genscript Biotech Corporation (GNNSF) compare to its historical average?